发明名称 RETINOID-LIKE COMPOUNDS, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT
摘要 organic chemistry, vitamins. SUBSTANCE: invention relates to compound of the formula (I): or its nontoxic pharmaceutically acceptable salt, physiologically hydrolyzable ester or solvate where X means -O-CO-, -NH-CO-, -CS-NH-, -CO-O-, -CO-NH-, -COS-, -SCH2-,CH2-CH2-,-C=C-,-CH2-NH-,-COCH2-, -NHCS-, -CH2S-,-CH2O-,-OCH2-,-NHCH2- or -CR5=CR6-; Rm and Rk mean independently each of other hydrogen, halogen atom; ; n = 0 or 1; R4 means -(CH2)t--Y, C1-6-alkyl; R1 means -CO2Z; R2 and R3 are independently each of other hydrogen atom or C1-6-alkyl; Ra and Rb are independently each of other hydrogen atom or C1-6-alkyl; when n = 1 then Ra and Rb can form in common radical of the formula: ; Y means phenyl optionally substituted with C1-6-alkyl or halogen atom; Z means hydrogen atom or C1-6-alkyl; R5 and R6 are independently each of other hydrogen atom or C1-6-alkyl and t = 0. Invention relates to also methods of prophylaxis and/or treatment of patients with tumors, arthritis and nonmalignant skin pathology that involve administration of compound of the formula (I) to animals and to pharmaceutical composition containing the compound of the formula (I) with mixture of pharmaceutically acceptable carriers also. EFFECT: valuable medicinal properties of compound and composition. 48 cl, 2 tbl, 4 dwg, 163 ex
申请公布号 RU2163590(C2) 申请公布日期 2001.02.27
申请号 RU19960111015 申请日期 1996.06.04
申请人 BRISTOL' - MEJERZ SKVIBB KOMPANI 发明人 DZHON E. STEHRREHTT ML.;KUO-LONG JU.;MUZAMMIL M. MANSURI;DEHVID R. TORTOLANI;PETER R. REZHEK
分类号 C07C15/24;A61K;A61K31/015;A61K31/02;A61K31/035;A61K31/04;A61K31/045;A61K31/085;A61K31/095;A61K31/10;A61K31/11;A61K31/12;A61K31/122;A61K31/13;A61K31/135;A61K31/16;A61K31/165;A61K31/185;A61K31/19;A61K31/192;A61K31/196;A61K31/21;A61K31/215;A61K31/235;A61K31/265;A61P19/02;C07C;C07C13/48;C07C13/60;C07C15/27;C07C15/28;C07C25/22;C07C25/24;C07C31/02;C07C31/137;C07C33/34;C07C33/38;C07C33/50;C07C39/23;C07C39/42;C07C43/18;C07C43/20;C07C47/548;C07C47/55;C07C47/56;C07C47/575;C07C49/553;C07C49/76;C07C49/782;C07C49/792;C07C49/798;C07C49/813;C07C49/82;C07C49/84;C07C49/86;C07C63/04;C07C63/08;C07C63/15;C07C63/331;C07C63/36;C07C63/66;C07C65/01;C07C65/21;C07C65/30;C07C69/753;C07C69/76;C07C69/773;C07C69/84;C07C205/00;C07C205/06;C07C205/11;C07C205/19;C07C205/37;C07C205/43;C07C205/44;C07C205/57;C07C211/30;C07C211/31;C07C211/38;C07C211/45;C07C211/60;C07C215/50;C07C215/70;C07C215/76;C07C217/54;C07C217/58;C07C223/00;C07C229/38;C07C229/54;C07C229/60;C07C233/00;C07C233/61;C07C233/64;C07C233/81;C07C235/56;C07C235/84;C07C237/30;C07C319/00;C07C321/22;C07C321/28;C07C323/07;C07C323/09;C07C323/16;C07C323/18;C07C323/22;C07C323/27;C07C323/56;C07C323/62;C07C327/16;C07C327/26;C07C327/28;C07C327/32;C07C327/46;C07C327/48;(IPC1-7):C07C15/24 主分类号 C07C15/24
代理机构 代理人
主权项
地址